Multiple Sclerosis

Displaying 1 - 15 out of 15 guidelines found

  1. Summary of Comprehensive Systematic Review: Rehabilitation in Multiple Sclerosis

    November 2015

    Current systematic review. Endorsed by the MS Foundation. Reaffirmed on January 20, 2018.

  2. Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders

    April 2014

    Current systematic review. Endorsed by the American Autonomic Society, the American Epilepsy Society, the Consortium of Multiple Sclerosis Centers, the International Organization of Multiple Sclerosis Nurses, and the International Rett Syndrome Foundation.

  3. Summary of Evidence-Based Guideline: Complementary and Alternative Medicine in Multiple Sclerosis

    March 2014

    Current guideline. Endorsed by the Consortium of Multiple Sclerosis Centers and the International Organization of Multiple Sclerosis Nurses.

  4. Assessment and Management of Psychiatric Disorders in Individuals with Multiple Sclerosis

    January 2014

    Current guideline. Reaffirmed on July 16, 2016. Endorsed by the American Association of Neuroscience Nurses, the Consortium of Multiple Sclerosis Centers, and the International Organization of Multiple Sclerosis Nurses.

  5. Clinical Evaluation and Treatment of Transverse Myelitis

    December 2011

    Current guideline; reaffirmed on January 24, 2015. Endorsed by The Consortium of MS Centers. The American Academy of Neurology is to be congratulated for thoughtfully assessing the current status of evidence-based information and for revealing the need for much work before credible algorithms can be applied to the treatment of this syndrome.

  6. Update: Plasmapheresis in Neurologic Disorders

    January 2011

    Current guideline. Reaffirmed on January 23, 2016. Endorsed by the American Association of Neuromuscular and Electrodiagnostic Medicine. The National Multiple Sclerosis Society endorsed only the section that relates to the use of plasma exchange for multiple sclerosis.

  7. Evidence Report: The Efficacy and Safety of Mitoxantrone (Novantrone) in the Treatment of Multiple Sclerosis

    May 2010

    Update in progress. Reaffirmed on July 13, 2013.

  8. The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis

    September 2008

    Retired guideline.

  9. Neutralizing Antibodies to Interferon-beta: Assessment of Their Clinical and Radiographic Impact

    March 2007

    Current guideline. Reaffirmed on July 10, 2010, July 13, 2013, and January 23, 2016.

  10. The Use of Mitoxantrone (Novantrone) for the Treatment of Multiple Sclerosis

    November 2003

    Update in progress. Reaffirmed on July 13, 2013.

  11. Utility of MRI in Suspected MS

    September 2003

    Retired by the AAN Institute Board of Directors on March 8, 2016.

  12. Immunization and Multiple Sclerosis: A Summary of Published Evidence and Recommendations

    December 2002

    Update in progress. Reaffirmed on December 9, 2006.

  13. Disease Modifying Therapies in Multiple Sclerosis

    February 2002

    Update in progress. Reaffirmed October 17, 2003 and July 19, 2008. Replaces "Practice Advisory on Selection of Patients with Multiple Sclerosis for Treatment with Betaseron" (August 1994).

  14. The Usefulness of Evoked Potentials in Identifying Clinically Silent Lesions in Patients with Suspected Multiple Sclerosis

    May 2000

    Current guideline. Reaffirmed on October 18, 2003, January 13, 2007, and August 2, 2008.

  15. The Relationship of MS to Physical Trauma and Psychological Stress

    June 1999

    Retired guideline

Questions?

Email guidelines@aan.com

Call (800) 879-1960 or (612) 928-6000 (international)

Top

Footer